The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis

INTRODUCTION: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have an extremely important impact on the treatment of hormone-sensitive breast cancer (BC) and have radically changed the first-line treatment for metastatic disease with increased rates of treatment response, overall survival (OS), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrelli, Fausto, Dottorini, Lorenzo, Di Menna, Giandomenico, Borgonovo, Karen, Parati, Maria Chiara, Rea, Carmen Giusy, Ghilardi, Mara, Ghidini, Antonio, Luciani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512091/
https://www.ncbi.nlm.nih.gov/pubmed/37198053
http://dx.doi.org/10.1016/j.breast.2023.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512091/
https://www.ncbi.nlm.nih.gov/pubmed/37198053
http://dx.doi.org/10.1016/j.breast.2023.05.002

Ejemplares similares